Guideline-based management of asthma focuses on disease severity and choosing the
appropriate medical therapy to control symptoms and reduce the risk of exacerbations …

BackgroundThe efficacy of psychopharmacological treatments has been called into
question. Psychiatrists are unfamiliar with the effectiveness of common medical drugs …

BACKGROUND: Asthma is an inflammatory condition often punctuated by episodic
symptomatic worsening, and accordingly, patients with asthma might have waxing and …

Asthma is a highly prevalent chronic respiratory disease affecting 300 million people world‐
wide. A significant fraction of the cost and morbidity of asthma derives from acute care for …

Background The contributions of as-needed inhaled corticosteroids and long-acting β2
agonists (LABA) to asthma control have not been fully established. We compared the …

BACKGROUND: Budesonide/formoterol maintenance and reliever therapy (Symbicort
SMART®) improves asthma control compared with fixed-dose inhaled corticosteroid/long …

Background New evidence has suggested that people with asthma who are homozygous for
arginine at aminoacid 16 of the β 2-adrenergic receptor (ADRB2) might not benefit from …

Exercise-induced bronchoconstriction (EIB) describes airway narrowing that occurs in
association with exercise. EIB occurs in up to 90% of asthmatic patients and is estimated to …

The vastness of clinical data and the progressing specialization of medical knowledge may
lead to misinterpretation of medication efficacy. To show a realistic perspective on drug …

Objective: To systematically review the evidence for the medium to long term benefits and
risks of montelukast as add-on therapy to inhaled corticosteroids (ICS) in comparison with …